If you have any other questions about the use of this medication, ask your doctor or pharmacist.
It is essential that you know which side effects could occur. Some side effects ofCandesartán/ Hidroclorotiazida ratiomedare due to candesartán cilexetilo and others are due to hydrochlorothiazide.
Stop taking Candesartán /Hidroclorotiazida ratiomed and see your doctor immediately if you experience any of the following severe reactions:
Rare (may affect up to 1 in 100 people):
Uncommon (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Candesartán/ Hidroclorotiazida ratiomed may cause a decrease in white blood cells. Your resistance to infections may decrease, and you may feel tired, have an infection, or fever. If this occurs, inform your doctor. It is possible that your doctor will perform blood tests at regular intervals to check that Candesartán/ Hidroclorotiazida ratiomed is not affecting your blood (agranulocytosis).
Other possible side effects include:
Common (may affect up to 1 in 10 people)
Rare (may affect up to 1 in 100 people)
Uncommon (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Frequency unknown (cannot be estimated from available data)
Reporting side effects
If you experience any type of side effects,consult your doctor or pharmacist,eveniftheydo not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not usethis medicationafter the expiration date that appears on the packaging or blister. The expiration date is the last day of the month indicated.
Do not store at a temperature above 25°C.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection pointof the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. By doing so, you will help protect the environment.
Composition of Candesartán/ Hidroclorotiazida ratiomed
- The active principles are candesartán cilexetilo and hidroclorotiazida. Each tablet contains 8 mg of candesartán cilexetilo and 12.5 mg of hidroclorotiazida.
- The other components are: pregelatinized cornstarch, povidone K-30, calcium carmelose, poloxamer 188, microcrystalline cellulose, lactose monohydrate (dried by spray drying), magnesium stearate.
Appearance of the product and contents of the package
Candesartán /Hidroclorotiazida ratiomed 8 mg/12.5 mg are white or almost white tablets, in capsule shape, biconvex, one face of the tablets is scored and engraved with “C” on the left side of the score and with “8” on the right side of the score. The other face of the tablet is scored.
Candesartán/ Hidroclorotiazida ratiomed 8 mg/12.5 mgis available in package sizes of 7, 10, 14, 15, 28, 30, 50, 56, 90, 98, 100, 300 tablets; 28 x 1, 50 x 1, 56 x 1, and 98 x 1 single-dose blisters (hospital pack).
Only some package sizes may be commercially available.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Teva Pharma, S.L.U.
c/ Anabel Segura 11, Edificio Albatros B 1st floor
28108 Alcobendas, Madrid (Spain)
Responsible for manufacturing:
TEVA Pharmaceutical Works Private Limited Company
Pallagi út 13, 4042 Debrecen
Hungary
Or
Pharmachemie B.V.
Swensweg 5, Postbus 552, 2003 RN Haarlem
Netherlands
Or
Teva Operations Poland Sp. z o.o.
ul. Mogilska 80 31-546, Cracow
Poland
Or
PLIVA Croatia Ltd.
Prilaz baruna Filipovica 25, 10000 Zagreb
Croatia
This medicine is authorized in the member states of the European Economic Area with the following names:
Germany:Candesartan comp.AbZ
Spain:Candesartán/ Hidroclorotiazida ratiomed 8 mg/12.5 mg tablets EFG
Last review date of this leaflet: January 2025
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.